Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
MD VIROLOGIST's Profile
Displaying 101-150 of 672 result(s).
CYDY CytoDyn Inc
05/17/2021 11:02:48 PM
In my very humble opinion, I don't
CYDY CytoDyn Inc
05/17/2021 10:35:14 PM
You are right, I have done that ope (1)
CYDY CytoDyn Inc
05/12/2021 9:53:48 PM
My son is involved in that project
CYDY CytoDyn Inc
05/12/2021 7:56:20 PM
This may be interesting they will b (1)
CYDY CytoDyn Inc
05/10/2021 10:55:49 PM
Respert those numbers were before D
CYDY CytoDyn Inc
05/10/2021 10:41:56 PM
You are right, the number of interv (1)
CYDY CytoDyn Inc
05/10/2021 1:11:41 PM
I have no opinion on price point, I (2)
CYDY CytoDyn Inc
05/10/2021 12:27:19 PM
CAD is the cause of 80% of SCD. (1)
CYDY CytoDyn Inc
05/10/2021 12:24:47 PM
https://www.ncbi.nlm.nih.gov/books
CYDY CytoDyn Inc
05/10/2021 11:37:41 AM
For those interested this is the DO (2)
CYDY CytoDyn Inc
05/05/2021 2:48:49 PM
Very good question.
CYDY CytoDyn Inc
05/05/2021 10:57:28 AM
This is about vaccine patents mostl (2)
CYDY CytoDyn Inc
05/01/2021 10:11:23 AM
Dr. Ueno's research group at MD And
CYDY CytoDyn Inc
04/27/2021 5:36:17 PM
Well I am not popular here, but it (6)
CYDY CytoDyn Inc
04/26/2021 1:16:58 PM
The PI situation is interesting, re (2)
CYDY CytoDyn Inc
04/26/2021 9:18:10 AM
Correct you can check the progress
CYDY CytoDyn Inc
04/23/2021 2:31:05 PM
Lobectomy for coccidio? Well I thin (2)
CYDY CytoDyn Inc
04/22/2021 7:47:50 AM
Cost and the firm thinking RO was e (1)
CYDY CytoDyn Inc
04/22/2021 7:46:08 AM
I read NP's statements, he clearly (1)
CYDY CytoDyn Inc
04/22/2021 7:27:03 AM
We do need the tropism test once, i
CYDY CytoDyn Inc
04/22/2021 7:24:41 AM
That is exactly correct. and why th
CYDY CytoDyn Inc
04/21/2021 7:07:17 PM
Tropism demonstrates affinity, yes (2)
CYDY CytoDyn Inc
04/21/2021 7:03:37 PM
Also if anyone is interested (we ar (1)
CYDY CytoDyn Inc
04/21/2021 5:32:25 PM
On November 5, 2020, Pourhassan tol (2)
CYDY CytoDyn Inc
04/21/2021 3:16:00 PM
All very valid points. the MOA is b (1)
CYDY CytoDyn Inc
04/21/2021 7:23:48 AM
Exactly, probably one dose does not
CYDY CytoDyn Inc
04/20/2021 9:26:55 PM
Cardiogenic, neurogenic, and hypovo (1)
CYDY CytoDyn Inc
04/20/2021 9:25:26 PM
People in septic shock with capilla (1)
CYDY CytoDyn Inc
04/20/2021 9:20:19 PM
Sure and now for critical patients
CYDY CytoDyn Inc
04/20/2021 8:42:14 PM
Thirty years practicing in ICU's I
CYDY CytoDyn Inc
04/20/2021 8:36:37 PM
Which drug ?
CYDY CytoDyn Inc
04/20/2021 4:28:27 PM
If you remember my posts there is n (3)
CYDY CytoDyn Inc
04/19/2021 6:02:48 PM
My homeland, sad, about .15% of the (2)
CYDY CytoDyn Inc
04/15/2021 7:25:02 PM
SAF is clearly a good man, thank yo (3)
CYDY CytoDyn Inc
04/10/2021 9:02:50 PM
I have already quite honestly said
CYDY CytoDyn Inc
04/07/2021 8:35:39 PM
Because the c suite thought it was
CYDY CytoDyn Inc
04/07/2021 4:48:28 PM
I responded to someone who wished t
CYDY CytoDyn Inc
04/07/2021 11:15:45 AM
Extreme remedies are very appropria (1)
CYDY CytoDyn Inc
04/06/2021 4:53:37 PM
Sure but depending on the primary t
CYDY CytoDyn Inc
04/06/2021 11:42:42 AM
Lump met or primary? I suggest enro
CYDY CytoDyn Inc
04/03/2021 5:37:24 PM
I would like to explain something,I (3)
CYDY CytoDyn Inc
04/03/2021 8:24:30 AM
Precision medicine conference in th (2)
CYDY CytoDyn Inc
04/02/2021 10:57:16 AM
Correct, that’s why I think a co (2)
CYDY CytoDyn Inc
04/02/2021 10:49:28 AM
I agree not worried about liver tox
CYDY CytoDyn Inc
04/01/2021 5:50:10 PM
I probably was not clear I thought (3)
CYDY CytoDyn Inc
04/01/2021 5:00:28 PM
Possible obstacles, the polemic is (1)
CYDY CytoDyn Inc
04/01/2021 4:53:00 PM
Right going IV could be different,
CYDY CytoDyn Inc
04/01/2021 4:23:17 PM
I will be honest I don’t do DD wi
CYDY CytoDyn Inc
04/01/2021 4:00:18 PM
Not a bashing or feeding the swamp (2)
CYDY CytoDyn Inc
04/01/2021 3:56:16 PM
Thank you I can carve half a pancre
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • MindHYVE.ai™ Joins Forces with Smart Learnify for AI Education
  • Yubi Group Welcomes Banking Expert Suvo Sarkar to Advisory
  • Stora Enso Welcomes Jutta Mikkola as New IR Leader
  • Orion to Discuss Growth and Strategy at Capital Markets Day
  • Alchip Technologies Reports Remarkable Q1 Growth Metrics
  • Experience the Innovative Design of Honka Kömmeli Housing Fair
  • Nokia and Three Sweden Revolutionize Broadband with 5G Access
  • Exploring MuniFin's NOK 500 Million Social Bond Expansion
  • IDEX Biometrics Board Members Opt for Share-Based Remuneration
  • Integral Metals Unearths Potential at the Burntwood Project
  • Advantest Seizes Global Recognition as Top Test Equipment Supplier
  • Parcel Perform Elevates E-commerce Delivery with AI Decision Intelligence
  • Transforming Travel: Amadeus and Google Cloud Join Forces
  • Pigment and Google Cloud Join Forces to Enhance AI Business Planning
  • Dstny Welcomes Yann Le Helloco as New CPTO for Innovation
  • Dstny Welcomes Yann Le Helloco as New Chief Product Officer
  • SWS Medical's Vision: Transforming Kidney Care in the Americas
  • ThreatBook Sets the Benchmark in Cyber Threat Solutions
  • Exciting Advances in Tricuspid Valve Replacement with Topaz
  • Transplantation Market Growth Projected to Exceed USD 30B
  • Surge in Rehabilitation Robotic Systems Market Projected Growth
  • Future Growth of Thermal Forming Materials Market Explored
  • Understanding Invalda INVL's Dividend Payment Process for 2024
  • TCM Group A/S Reports Changes in Shareholder Holdings
  • Hyundai Motor Group's Bold Initiatives in Hydrogen Energy
  • OCI Global's Positive Momentum in Q1 2025 Trading Update
  • Honeywell Strengthens Catalyst Portfolio with Major Acquisition
  • Energizing Strategies: OCI Global's Resilient Q1 2025 Update
  • Hyundai Motor Group Advances Global Hydrogen Initiatives
  • The Moonhouse: A Symbol of Hope and Home on the Moon
  • Timekettle's Breakthroughs in AI-Powered Translation Technology
  • Revolutionizing Vehicle Dynamics: InfiMotion's TL 300 Drive System
  • LIfT BioSciences Highlights Groundbreaking Immunotherapy Advances
  • Retail Automation Growth Projected to Exceed USD 56 Billion
  • Upcoming Annual Meeting for BW Energy: Key Details Inside
  • Key Leadership Changes at Hargreave Hale AIM VCT PLC
  • Amaroq Minerals Shares an In-Depth Exploration Update
  • Equinor ASA: Key Insights on Share Allocations and Incentives
  • Euronext Unveils €425 Million OCEANEs Bond Offering for 2032
  • Significant Share Buyback Announcement by NB Private Equity Partners
  • Foresight Group Executes Strategic Share Buyback Initiative
  • Kenmare Resources Updates on Share Capital and Regulations
  • CheqUp and WeightWatchers Collaborate for GLP-1 Weight Loss
  • Endeavour Mining's Recent Share Buyback Activity Overview
  • Rubis Supervisory Board Updates and Shareholder Engagement Insights
  • Equinor ASA Declares Cash Dividend for Q4 2024 Shareholders
  • Skanska Secures Major Contract for New Bypass Near Prague
  • WIN SOURCE Climbs Ranks as a Top Global Electronics Distributor
  • Azentio Launches Revolutionary Amlock AML Solution Powered by AI
  • EverGen Infrastructure Takes Major Steps with New Management Team
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site